Dr. Teo Soleymani

It can improve blood flow. So depending on the wavelength you pick and where it overlies on the absorption curves makes a big difference. It's interesting that we talk about light and as a skin cancer surgeon, this is always been interesting to me in that we use UV light to treat certain conditions and we assume UV light is purely pathogenic. And I don't think that's the case.

It can improve blood flow. So depending on the wavelength you pick and where it overlies on the absorption curves makes a big difference. It's interesting that we talk about light and as a skin cancer surgeon, this is always been interesting to me in that we use UV light to treat certain conditions and we assume UV light is purely pathogenic. And I don't think that's the case.

And why I bring this up is one of the most common things we use light therapy for is patients with vitiligo, which is this autoimmune condition in which your immune system attacks the cells that produce our skin color. And the standard treatment is certain creams that suppress the immune system in the skin, phototherapy, eczema laser, which is a UV laser.

And why I bring this up is one of the most common things we use light therapy for is patients with vitiligo, which is this autoimmune condition in which your immune system attacks the cells that produce our skin color. And the standard treatment is certain creams that suppress the immune system in the skin, phototherapy, eczema laser, which is a UV laser.

And why I bring this up is one of the most common things we use light therapy for is patients with vitiligo, which is this autoimmune condition in which your immune system attacks the cells that produce our skin color. And the standard treatment is certain creams that suppress the immune system in the skin, phototherapy, eczema laser, which is a UV laser.

And then now the new world of immunotherapies by pill form, the JAK inhibitors have made a huge difference. If we thought, and I go back on this tangent because the more we think about it, the less we know. If we think UV is truly deleterious, then patients with vitiligo should have a higher incidence of skin cancer. And in fact, the opposite is true.

And then now the new world of immunotherapies by pill form, the JAK inhibitors have made a huge difference. If we thought, and I go back on this tangent because the more we think about it, the less we know. If we think UV is truly deleterious, then patients with vitiligo should have a higher incidence of skin cancer. And in fact, the opposite is true.

And then now the new world of immunotherapies by pill form, the JAK inhibitors have made a huge difference. If we thought, and I go back on this tangent because the more we think about it, the less we know. If we think UV is truly deleterious, then patients with vitiligo should have a higher incidence of skin cancer. And in fact, the opposite is true.

They have a lower incidence of skin cancer, even when you match them for amount of UV exposure over time. So it goes to tell us that there's so much about light and skin we don't understand, so much about sun and UV and skin we don't understand, and an incredible component about our skin's immune system that we're only now figuring out that play an important role.

They have a lower incidence of skin cancer, even when you match them for amount of UV exposure over time. So it goes to tell us that there's so much about light and skin we don't understand, so much about sun and UV and skin we don't understand, and an incredible component about our skin's immune system that we're only now figuring out that play an important role.

They have a lower incidence of skin cancer, even when you match them for amount of UV exposure over time. So it goes to tell us that there's so much about light and skin we don't understand, so much about sun and UV and skin we don't understand, and an incredible component about our skin's immune system that we're only now figuring out that play an important role.

Patients who have transplants, for example, Transplant patients in the early 90s, the number one cause of death for transplant patients that was not related to their transplant was metastatic skin cancer. And this was in patients who were strictly sun protected. So we talk about biology, photobiology, LED, UV, and skin health.

Patients who have transplants, for example, Transplant patients in the early 90s, the number one cause of death for transplant patients that was not related to their transplant was metastatic skin cancer. And this was in patients who were strictly sun protected. So we talk about biology, photobiology, LED, UV, and skin health.

Patients who have transplants, for example, Transplant patients in the early 90s, the number one cause of death for transplant patients that was not related to their transplant was metastatic skin cancer. And this was in patients who were strictly sun protected. So we talk about biology, photobiology, LED, UV, and skin health.

And there's so much we don't know as we gather more data and look at populations and cohorts. So I don't know why I brought that up as a tangent.

And there's so much we don't know as we gather more data and look at populations and cohorts. So I don't know why I brought that up as a tangent.

And there's so much we don't know as we gather more data and look at populations and cohorts. So I don't know why I brought that up as a tangent.

Psoriasis is like the quintessential skin condition. I have it myself on my elbows and knees. And for about 100 years, it was thought to be a problem, a rash that is caused by too much skin turnover or excess skin proliferation. And for 100 years, we treated it the same way. We gave medicines that basically took the skin off, what we call keratolytics.

Psoriasis is like the quintessential skin condition. I have it myself on my elbows and knees. And for about 100 years, it was thought to be a problem, a rash that is caused by too much skin turnover or excess skin proliferation. And for 100 years, we treated it the same way. We gave medicines that basically took the skin off, what we call keratolytics.

Psoriasis is like the quintessential skin condition. I have it myself on my elbows and knees. And for about 100 years, it was thought to be a problem, a rash that is caused by too much skin turnover or excess skin proliferation. And for 100 years, we treated it the same way. We gave medicines that basically took the skin off, what we call keratolytics.